A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly developed antibody can restore immune responses in mice. Pancreatic cancer remains ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
A multinational collaboration co-led by the Garvan Institute of Medical Research, in collaboration with Rockefeller University, and Kyoto University Graduate School of Medicine, has uncovered a ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its Phase Ib/II study of ...
News-Medical.Net on MSN
COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses
This study shows that SARS-CoV-2 infection and vaccination generate strong, highly specific spike-binding immune responses ...
SAN FRANCISCO, CA / ACCESS Newswire / August 4, 2025 / CASI Pharmaceuticals, Inc. (CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ ...
The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...
Researchers have developed EVE-Vax, a computational design tool that creates synthetic SARS-CoV-2 spike proteins mimicking future immune-evading variants. These designed proteins enable early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback